Atezolizumab, an Anti-Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study
McDermott, David F, Sosman, Jeffrey A, Sznol, Mario, Massard, Christophe, Gordon, Michael S, Hamid, Omid, Powderly, John D, Infante, Jeffrey R, Fassò, Marcella, Wang, Yan V, Zou, Wei, Hegde, Priti S, Fine, Gregg D, Powles, Thomas
Published in Journal of clinical oncology (10.03.2016)
Published in Journal of clinical oncology (10.03.2016)
Get full text
Journal Article
Platinum ineligibility and survival outcomes in patients with advanced urothelial carcinoma receiving first-line treatment
Gupta, Shilpa, Andreev-Drakhlin, Alexander, Fajardo, Otto, Fassò, Marcella, Garcia, Jorge A, Wee, Christopher, Schröder, Carsten
Published in JNCI : Journal of the National Cancer Institute (05.04.2024)
Published in JNCI : Journal of the National Cancer Institute (05.04.2024)
Get full text
Journal Article
Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I Study
Petrylak, Daniel P, Loriot, Yohann, Shaffer, David R, Braiteh, Fadi, Powderly, John, Harshman, Lauren C, Conkling, Paul, Delord, Jean-Pierre, Gordon, Michael, Kim, Joseph W, Sarkar, Indrani, Yuen, Kobe, Kadel, 3rd, Edward E, Mariathasan, Sanjeev, O'Hear, Carol, Narayanan, Sujata, Fassò, Marcella, Carroll, Susheela, Powles, Thomas
Published in Clinical cancer research (15.06.2021)
Published in Clinical cancer research (15.06.2021)
Get full text
Journal Article
Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab
Hamid, Omid, Molinero, Luciana, Bolen, Christopher R, Sosman, Jeffrey A, Muñoz-Couselo, Eva, Kluger, Harriet M, McDermott, David F, Powderly, John D, Sarkar, Indrani, Ballinger, Marcus, Fassò, Marcella, O'Hear, Carol, Chen, Daniel S, Hegde, Priti S, Hodi, F Stephen
Published in Clinical cancer research (15.10.2019)
Published in Clinical cancer research (15.10.2019)
Get full text
Journal Article
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model
Yu, Ping, Steel, Jason C, Zhang, Meili, Morris, John C, Waitz, Rebecca, Fasso, Marcella, Allison, James P, Waldmann, Thomas A
Published in Proceedings of the National Academy of Sciences - PNAS (17.04.2012)
Published in Proceedings of the National Academy of Sciences - PNAS (17.04.2012)
Get full text
Journal Article
A Potent and Effective Suicidal Listeria Vaccine Platform
Hanson, William G, Benanti, Erin L, Lemmens, Edward E, Liu, Weiqun, Skoble, Justin, Leong, Meredith L, Rae, Chris S, Fassò, Marcella, Brockstedt, Dirk G, Chen, Chen, Portnoy, Daniel A, Dubensky, Jr, Thomas W, Lauer, Peter
Published in Infection and immunity (01.08.2019)
Published in Infection and immunity (01.08.2019)
Get full text
Journal Article
Augmented IL-15Rα expression by CD40 activation is critical in synergistic CD8 T cell-mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in mice
Zhang, Meili, Ju, Wei, Yao, Zhengsheng, Yu, Ping, Wei, Bih-Rong, Simpson, R Mark, Waitz, Rebecca, Fassò, Marcella, Allison, James P, Waldmann, Thomas A
Published in The Journal of immunology (1950) (15.06.2012)
Published in The Journal of immunology (1950) (15.06.2012)
Get full text
Journal Article
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
Fassò, Marcella, Waitz, Rebecca, Hou, Yafei, Rim, Tae, Greenberg, Norman M, Shastri, Nilabh, Fong, Lawrence, Allison, James P
Published in Proceedings of the National Academy of Sciences - PNAS (04.03.2008)
Published in Proceedings of the National Academy of Sciences - PNAS (04.03.2008)
Get full text
Journal Article
A New Look at MHC and Autoimmune Disease
Ridgway, William M., Fassò, Marcella, Fathman, C. Garrison
Published in Science (American Association for the Advancement of Science) (30.04.1999)
Published in Science (American Association for the Advancement of Science) (30.04.1999)
Get full text
Journal Article
Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab-Response
Hamid, Omid, Bruno, Rene, Fasso, Marcella, O'Hear, Carol, Wu, Benjamin
Published in Clinical cancer research (15.05.2020)
Published in Clinical cancer research (15.05.2020)
Get full text
Journal Article
Abstract 2616: Baseline blood lymphocytes are associated with improved clinical outcome in atezolizumab-treated patients across multiple indications
Li, Yijin, Chang, Ching-Wei, Fasso, Marcella, O'Hear, Carol, Hegde, Priti S., Molinero, Luciana
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition
Sundar, Raghav, Huang, Kie-Kyon, Kumar, Vikrant, Ramnarayanan, Kalpana, Demircioglu, Deniz, Her, Zhisheng, Ong, Xuewen, Bin Adam Isa, Zul Fazreen, Xing, Manjie, Tan, Angie Lay-Keng, Tai, David Wai Meng, Choo, Su Pin, Zhai, Weiwei, Lim, Jia Qi, Das Thakur, Meghna, Molinero, Luciana, Cha, Edward, Fasso, Marcella, Niger, Monica, Pietrantonio, Filippo, Lee, Jeeyun, Jeyasekharan, Anand D, Qamra, Aditi, Patnala, Radhika, Fabritius, Arne, De Simone, Mark, Yeong, Joe, Ng, Cedric Chuan Young, Rha, Sun Young, Narita, Yukiya, Muro, Kei, Guo, Yu Amanda, Skanderup, Anders Jacobsen, So, Jimmy Bok Yan, Yong, Wei Peng, Chen, Qingfeng, Göke, Jonathan, Tan, Patrick
Published in Gut (01.07.2022)
Published in Gut (01.07.2022)
Get full text
Journal Article
Abstract PD10-04: Phase Ib/II open-label, randomized trial of atezolizumab (atezo) with ipatasertib (ipat) and fulvestrant (fulv) vs control in MORPHEUS-HR+ breast cancer (M-HR+ BC) and atezo with ipat vs control in MORPHEUS triple negative breast cancer (M-TNBC)
Hurvitz, Sara A., Boni, Valentina, Comen, Elizabeth, Im, Seock-Ah, Jung, Kyung Hae, Kim, Sung-Bae, Lee, Keun Seok, Loi, Sherene, Rugo, Hope S., Sonnenblick, Amir, Telli, Melinda L., DuPree, Kelly, Fasso, Marcella, Lin, Ya-Chen, Nikanjam, Mina, Schimmoller, Frauke, Zhang, Xiaosong, Zhu, Jing, Schmid, Peter
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Get full text
Journal Article
Clinical activity, safety and biomarker results from a phase Ia study of atezolizumab (atezo) in advanced/recurrent endometrial cancer (rEC)
Fleming, Gini F., Emens, Leisha A., Eder, Joseph Paul, Hamilton, Erika Paige, Liu, Joyce F., Liu, Bo, Molinero, Luciana, Fasso, Marcella, O'Hear, Carol, Braiteh, Fadi S.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
MORPHEUS: A phase Ib/II multi-trial platform evaluating the safety and efficacy of cancer immunotherapy (CIT)-based combinations in patients (pts) with non-small cell lung cancer (NSCLC)
Johnson, Melissa Lynne, Solomon, Benjamin J., Awad, Mark M., Cho, Byoung Chul, Gainor, Justin F., Goldberg, Sarah B., Keam, Bhumsuk, Lee, Dae Ho, Huang, Chen, Helms, Hans-Joachim, Barak, Hila, Fasso, Marcella, Bleul, Conrad, Cha, Edward, Rizvi, Naiyer A.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
A phase Ia study of safety and clinical activity of atezolizumab (atezo) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
Kim, Joseph W., Shaffer, David R., Massard, Christophe, Powles, Thomas, Harshman, Lauren Christine, Braiteh, Fadi S., Conkling, Paul R., Sarkar, Indrani, Kadel, Edward E., Mariathasan, Sanjeev, O'Hear, Carol, Schiff, Christina, Fasso, Marcella, Carroll, Susheela, Petrylak, Daniel Peter
Published in Journal of clinical oncology (20.02.2018)
Published in Journal of clinical oncology (20.02.2018)
Get full text
Journal Article
Abstract 2986: Atezolizumab in metastatic TNBC (mTNBC): Long-term clinical outcomes and biomarker analyses
Schmid, Peter, Cruz, Cristina, Braiteh, Fadi S., Eder, Joseph Paul, Tolaney, Sara, Kuter, Irene, Nanda, Rita, Chung, Cathie, Cassier, Philippe, Delord, Jean-Pierre, Gordon, Michael, Li, Yijin, Liu, Bo, O’Hear, Carol, Fasso, Marcella, Molinero, Luciana, Emens, Leisha A.
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article
Atezolizumab (atezo) in patients with metastatic urothelial carcinoma (mUC): A 2-year clinical update from a phase Ia study
Petrylak, Daniel Peter, Powles, Thomas, Bellmunt, Joaquim, Braiteh, Fadi S., Loriot, Yohann, Morales, Rafael, Burris, Howard A., Kim, Joseph W., Ding, Beiying, Chang, Dannis, Fasso, Marcella, O'Hear, Carol, Vogelzang, Nicholas J.
Published in Journal of clinical oncology (20.02.2017)
Published in Journal of clinical oncology (20.02.2017)
Get full text
Journal Article
Abstract 2859: Inhibition of PD-L1 by MPDL3280A leads to clinical activity in patients with metastatic triple-negative breast cancer (TNBC)
Emens, Leisha A., Braiteh, Fadi S., Cassier, Philippe, Delord, Jean-Pierre, Eder, Joseph Paul, Fasso, Marcella, Xiao, Yuanyuan, Wang, Yan, Molinero, Luciana, Chen, Daniel S., Krop, Ian
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Get full text
Journal Article